Literature DB >> 2741341

Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule.

J M Wood1, J S Oxford, U Dunleavy, R W Newman, D Major, J S Robertson.   

Abstract

The immunogenicity and protective efficacy of formalin-inactivated vaccines prepared from influenza A (H1N1) viruses grown in MDCK cells and in eggs was compared in animal models. The A/Chr/157/83 virus grown in MDCK cells (157M) differed by two amino acid substitutions in the HA molecule from the corresponding virus grown in eggs (157E) and the two viruses could be distinguished antigenically by monoclonal and polyclonal antibodies. Following two intramuscular injections of vaccine in ferrets, guinea pigs, and hamsters, both vaccines were equally immunogenic when antibody was analyzed by hemagglutination inhibition using homologous virus. However, single radial hemolysis analysis following antibody cross-adsorption showed that antibody stimulated by 157E vaccine was exclusively strain specific whereas that produced by the 157M vaccine was more broadly reactive. When immunized hamsters were challenged with virus cultivated on mammalian (MDCK) cells, the homologous vaccine induced a higher degree of protection than the corresponding egg-grown vaccine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2741341     DOI: 10.1016/0042-6822(89)90528-x

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

1.  Immunogenicity and protective efficacy in mice of influenza B virus vaccines grown in mammalian cells or embryonated chicken eggs.

Authors:  I V Alymova; S Kodihalli; E A Govorkova; B Fanget; C Gerdil; R G Webster
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Systemic dissemination of H5N1 influenza A viruses in ferrets and hamsters after direct intragastric inoculation.

Authors:  Kyoko Shinya; Akiko Makino; Hiroji Tanaka; Masato Hatta; Tokiko Watanabe; Mai Q Le; Hirotaka Imai; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

Review 3.  Cell culture-based influenza vaccines: A necessary and indispensable investment for the future.

Authors:  Nagendra R Hegde
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus.

Authors:  J M Katz; M Wang; R G Webster
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

5.  A host-cell-selected variant of influenza B virus with a single nucleotide substitution in HA affecting a potential glycosylation site was attenuated in virulence for volunteers.

Authors:  J S Oxford; G C Schild; T Corcoran; R Newman; D Major; J Robertson; J Bootman; P Higgins; W al-Nakib; D A Tyrrell
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

Review 6.  Why Glycosylation Matters in Building a Better Flu Vaccine.

Authors:  Deborah Chang; Joseph Zaia
Journal:  Mol Cell Proteomics       Date:  2019-10-11       Impact factor: 5.911

7.  Syrian Hamster as an Animal Model for the Study of Human Influenza Virus Infection.

Authors:  Kiyoko Iwatsuki-Horimoto; Noriko Nakajima; Yurie Ichiko; Yuko Sakai-Tagawa; Takeshi Noda; Hideki Hasegawa; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

Review 8.  Cell-based influenza vaccines: progress to date.

Authors:  Jennifer M Audsley; Gregory A Tannock
Journal:  Drugs       Date:  2008       Impact factor: 9.546

9.  Influenza A virus lacking M2 protein as a live attenuated vaccine.

Authors:  Shinji Watanabe; Tokiko Watanabe; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

10.  Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective.

Authors:  S Kodihalli; D M Justewicz; L V Gubareva; R G Webster
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.